DCM
LMDXW

Dupont Capital Management’s LumiraDx Limited Warrant LMDXW Stock Holding History

Dupont Capital Management’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,500
Closed -$4K – 1820
2021
Q4 		$4K Hold
2,500
– – ﹤0.01% 1673
2021
Q3 		$3K Buy
+2,500
New +$2.9K ﹤0.01% 1687

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Dupont Capital Management's LMDXW Position: Q1 2022 in Review

Dupont Capital Management sold out of LumiraDx Limited Warrant (LMDXW) in Q1 2022, closing a stake of 2,500 shares — an estimated $4K sold.

Dupont Capital Management first reported a position in LMDXW in Q3 2021 and held it in 2 quarters. The position peaked at $4K in Q4 2021. 20 funds tracked by Wall St. Rank hold LMDXW as of Q1 2022.

  • Dupont Capital Management reported no remaining LumiraDx Limited Warrant position as of Q1 2022 after selling out during the quarter.
  • Dupont Capital Management sold 2,500 LumiraDx Limited Warrant shares in Q1 2022, an estimated $4K.
  • Dupont Capital Management first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 2 quarters.
  • Dupont Capital Management's LumiraDx Limited Warrant position peaked at $4K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q1 2022.

Based on Dupont Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.